roger hao wrote: My original point - that thousands are getting a result from ivermectin.
Isn't that how trials work? It isn't just me.
. ICON Clinical Study Results
The ICON study, which was a multihospital retrospective cohort study, involved 280 patients, 173 patients were treated with at least one oral dose of 200 μg/kg ivermectin and 107 patients had no ivermectin treatment. Patients could also be treated with hydroxychloroquine, azithromycin, or both.
The results from this study showed that:
Overall mortality was significantly lower for the ivermectin group (15%) compared to the usual treatment group (25.2%) using figures from the unmatched cohort.
Mortality for the subgroup of patients who had severe pulmonary involvement was lower in the ivermectin treatment group (38.8%) compared to the usual treatment group (80.7%) from the unmatched cohort.
There was no significant difference between the two treatment groups regarding successful extubation rates of mechanically ventilated patients. Successful extubation is when the patient has had the breathing tube that has been used for mechanical ventilation removed and they can successfully breath on their own.
Length of hospital stay was not significantly different between the ivermectin treatment group and the regular treatment group.
Bottom line
Clinical trials in the laboratory (in vitro) on ivermectin show that ivermectin reduces the number of cell-associated viral RNA by 99.8 % in 24 hours, for the SARS-CoV-2 which is the virus that causes COVID-19.
More studies are needed to see if these positive results will be the same in human testing (in vivo) and whether ivermectin will decrease the symptoms, time for recovery and death rate from COVID-19.
Ivermectin is already a FDA approved medicine for some types of intestinal worms
It is known that ivermectin has a good safety profile at standard dosing levels.
Official Answer
by Drugs.com
Ivermectin has been trialled in treating the coronavirus SARS-CoV-2, which is the virus that causes COVID-19.
An in vitro trial has shown ivermectin reduces the number of cell-associated viral RNA by 99.8 % in 24 hours. An in vitro study is when they study cells in a laboratory and not in a living organism.
More studies are now needed to be done using ivermectin on people or animals to see how well ivermectin works against COVID-19. This is in vivo testing.
Ivermectin is currently a FDA approved medicine for treatment of intestinal worms, Strongyloides stercoralis and Onchocerca volvulus. It has been established as safe for human use.
Giles wrote:What goes around, comes around...
"Kenyan anti-vaccine doctor dies from Covid-19" ... https://www.bbc.com/news/world-africa-56922517
Return to Been There Done That
Users browsing this forum: No registered users and 5 guests